Authors' reply
Dr Lamb adds important information on the good stability of a1-microglobulin in the urine. This is noteworthy and con£icting data that we had not been aware of when compiling our references. 1 From this data, we concur with Dr Lamb that the stability of cystatin C and a1-microglobulin in the urine appear highly comparable, with similarly simple measurement and thus clinical applicability. Furthermore, Dr Lamb raises the important issue regarding the diagnostic value of each of these parameters. In our further study, urine cystatin C demonstrated a better prognostic value than a1-microglobulin di¡erentiating patients requiring renal replacement therapy from those not requiring replacement therapy in acute tubular necrosis. 2 However, this should only be considered a ¢rst study and our results require con¢rmation in a study with a larger patient sample before the question may be answered whether urinary cystatin C or a1-microglobulin provides better prognostic information in acute tubular necrosis.
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